Entrada Therapeutics, Inc.

TRDA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$101,211$67,602$45,157$291,064
Short-Term Investments$318,787$284,367$143,555$0
Receivables$3,680$5,878$0$0
Inventory$0$0$0$0
Other Curr. Assets$16,361$11,924$21,163$7,636
Total Curr. Assets$440,039$369,771$209,875$298,700
Property Plant & Equip (Net)$82,048$92,681$33,021$6,261
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$4,234$6,740$9,160$872
Total NC Assets$86,282$99,421$42,181$7,133
Other Assets$0$0$0$0
Total Assets$526,321$469,192$252,056$305,833
Liabilities
Payables$4,259$3,277$5,990$706
Short-Term Debt$7,559$7,909$8,406$0
Tax Payable$667$4,024$0$0
Deferred Revenue$13,654$132,261$0$0
Other Curr. Liab.$13,343$11,325$7,576$6,013
Total Curr. Liab.$39,482$158,796$21,972$6,719
LT Debt$51,648$60,321$17,530$0
Deferred Rev, NC$6,513$7,715$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$396
Total NC Liab.$58,161$68,036$17,530$396
Other Liabilities$0$0$0$0
Cap. Leases$59,207$68,230$25,936$0
Total Liabilities$97,643$226,832$39,502$7,115
Equity
Pref Stock$0$0$0$0
Common Stock$4$3$3$3
Retained Earnings-$129,344-$194,970-$188,285-$93,669
AOCI-$43$195-$2,057$0
Other Equity$558,061$437,132$402,893$392,384
Total Equity$428,678$242,360$212,554$298,718
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$526,321$469,192$252,056$305,833
Net Debt-$42,004$628-$19,221-$291,064
Entrada Therapeutics, Inc. (TRDA) Financial Statements & Key Stats | AlphaPilot